Home > Newsletters > International Pharmaceutical Regulatory Monitor > U.S. Must Work With Developing Nations to Ensure Safer Imports, IOM Says
International Pharmaceutical Regulatory Monitor
May 2012 | Vol. 40 No. 5
U.S. Must Work With Developing Nations to Ensure Safer Imports, IOM Says
The U.S. Food and Drug Administration (FDA) and other agencies must provide expertise, training and tools to developing nations to improve their pharma monitoring practices and prevent dangerous drugs and medical products from entering the U.S., according to an April 4 Institute of Medicine (IOM) report.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.